Cargando…
An In Ovo Model for Testing Insulin-mimetic Compounds
Elevated blood glucose levels in type 2 diabetes mellitus (T2DM), a complex and multifactorial metabolic disease, are caused by insulin resistance and β-cell failure. Various strategies, including the injection of insulin or the usage of insulin-sensitizing drugs, were pursued to treat T2DM or at le...
Autores principales: | Haselgrübler, Renate, Stübl, Flora, Stadlbauer, Verena, Lanzerstorfer, Peter, Weghuber, Julian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MyJove Corporation
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100700/ https://www.ncbi.nlm.nih.gov/pubmed/29733303 http://dx.doi.org/10.3791/57237 |
Ejemplares similares
-
Insulin Mimetic Properties of Extracts Prepared from Bellis perennis
por: Haselgrübler, Renate, et al.
Publicado: (2018) -
Identification of novel insulin mimetic drugs by quantitative total internal reflection fluorescence (TIRF) microscopy
por: Lanzerstorfer, Peter, et al.
Publicado: (2014) -
Gluc-HET, a complementary chick embryo model for the characterization of antidiabetic compounds
por: Haselgrübler, Renate, et al.
Publicado: (2017) -
Hypolipidemic effects of herbal extracts by reduction of adipocyte differentiation, intracellular neutral lipid content, lipolysis, fatty acid exchange and lipid droplet motility
por: Haselgrübler, Renate, et al.
Publicado: (2019) -
Biomolecular Characterization of Putative Antidiabetic Herbal Extracts
por: Stadlbauer, Verena, et al.
Publicado: (2016)